Jiang Chunyang, Hu Xiaoli, Alattar Mohamed, Zhao Hui
Department of Thoracic Surgery, Tianjin Union Medicine Centre, 190 Jieyuan Road, Hongqiao District, Tianjin 300121, Tianjin, People's Republic of China.
Expert Rev Anticancer Ther. 2014 Apr;14(4):453-61. doi: 10.1586/14737140.2013.870037. Epub 2014 Feb 9.
miRNAs, which are small single-stranded RNA molecules composed of 18-23 nts, act as oncogenes or tumor suppressor genes playing important roles in the processes of tumor formation, infiltration and metastasis. Lung cancer currently has the highest morbidity and mortality among all malignant tumors; yet, lack of early specific diagnostic markers and effective treatments hinders its proper management. In lung cancer, about 40-45 abnormal expression patterns of miRNAs have been discovered and are involved in lung cancer development. miRNAs have functions together with oncogenes and tumor suppressor genes of lung cancer. miRNAs-based tests can be used for early clinical diagnosis and prediction of clinical outcomes of lung cancer. Studying the role of miRNAs in lung cancer development and its relationship with diagnostic and prognostic parameters might help to improve the sensitivity of diagnosis and the efficacy of lung cancer treatment.
微小RNA(miRNAs)是由18 - 23个核苷酸组成的小单链RNA分子,作为癌基因或肿瘤抑制基因,在肿瘤形成、浸润和转移过程中发挥重要作用。肺癌目前在所有恶性肿瘤中发病率和死亡率最高;然而,缺乏早期特异性诊断标志物和有效治疗方法阻碍了其合理管理。在肺癌中,已发现约40 - 45种miRNAs异常表达模式,并参与肺癌发展。miRNAs与肺癌的癌基因和肿瘤抑制基因共同发挥作用。基于miRNAs的检测可用于肺癌的早期临床诊断和临床结局预测。研究miRNAs在肺癌发展中的作用及其与诊断和预后参数的关系可能有助于提高诊断敏感性和肺癌治疗效果。